anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Disclaimer

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 41,117
Current window 30,121-30,150
Pages 1,371
Rows per page 30
Component: Disclaimerclear collectionreset all
18 30 60

Component

30,121-30,150 of 41,117

filter-aware
14
The slide uses a table to show historical growth in product registrations and household segments, followed by a calculation of the total addressable incremental revenue.Sonos | Investor Presentation Deck | 20 slides · Sonos
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
Includes disclaimer regarding non-GAAP measures and forward-looking statements.Sonos | Investor Presentation Deck | 20 slides · Sonos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
The table includes year-over-year growth percentages and non-GAAP operating expense breakdowns.Sonos | Investor Presentation Deck | 20 slides · Sonos
Pitch deck Investor relations Beat · Financials1 hit
03
Includes disclaimer regarding non-GAAP measures.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations Beat · Problem1 hit
04
Includes regional sales breakdown and non-GAAP measure disclaimers.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations Beat · Problem1 hit
06
The slide provides a reconciliation of GAAP to Non-GAAP operating expenses.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
The slide includes a disclaimer about non-GAAP measures and rounding.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
Slide includes a disclaimer about rounding and unaudited figures.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide uses a table to contrast financial performance metrics and a bulleted list for qualitative context.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
26
The slide uses a chevron-style arrow to imply progression from current state to future state.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 1 hit
28
Includes non-GAAP reconciliations and constant currency metrics.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 1 hit
42
The slide uses a two-part growth model to explain revenue performance.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations 1 hit
44
The slide uses a four-column layout to highlight key financial metrics with corresponding footnotes.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations 1 hit
63
Standard financial disclosure regarding non-GAAP measures.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Action1 hit
02
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations 1 hit
07
The slide compares previous vs updated guidance for FY 2023 and break-even targets.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
10
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations 1 hit
11
Includes a footnote explaining the composition of 'Financial income, net'.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations 1 hit
01
Slide 1
Theravance Biopharma | Results Presentation Deck | 41 slidesTheravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Attention1 hit
04
Theravance Biopharma | Results Presentation Deck | 41 slidesTheravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Attention1 hit
06
Uses a before-after framing to show goal alignment.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
07
Uses a simple before-after framing to track progress against specific financial goals.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
14
The slide outlines a clinical trial methodology including randomization, treatment duration, and primary/secondary endpoints.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
18
Uses a before-after framing to explain the mechanism of action for Ampreloxetine.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
19
The slide uses a process-flow layout to connect mechanism to clinical outcomes.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
24
Includes GAAP and non-GAAP financial data.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
26
The slide emphasizes the company's improved financial position, specifically the reduction in debt and share buybacks.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
31
Standard pharmaceutical product disclosure slide.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
34
Includes definitions for COPD, nOH, and PTE in the footer.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
36
The table displays projected royalties and milestones for 2023-2026, while the right side details royalty return dates for 2029 and 2031.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit